✨ 9 results found - Searched 21220 records in 4ms.
Tesis
Analisis Potensi Interaksi Obat Pada Tatalaksana Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut di RS Kanker Dharmais Tahun 2023
2024 | BY Anggi Gayatri - Purwantyastuti Ascobat - Noorwati Soetandyo - Yolanda Safitri- Analysis of Potential Drug Interactions in the Management of Non-Small Cell Carcinoma Lung Cancer (NSCLC) Advanced Stage at Dharmais Cancer Hospital in 2023.
- Nomor Panggil T24404fk
Disertasi
Peran MicroRNA-224 dan MicroRNA-544a, serta Sel Punca Kanker terhadap Respons Kemoterapi Berbasis Platinum Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut
2024 | BY Lisnawati - Asmarinah. - Elisna Syahruddin - Erna Kristiani- The Role of MicroRNA-224 dan MicroRNA-544a and Its Stemness to the Resistance of Platinum-based Chemotherapy in Patient with Advanced Stage Non-Small Cell Lung Cancer.
- Nomor Panggil D24039fk
Disertasi
Pengaruh Melatonin terhadap Respons Klinis Karsinoma Sel Skuamosa Rongga Mulut Stadium Lanjut Lokal yang Diberi Kemoterapi Neoadjuvan: Kajian terhadap Ekspresi HIF-1α, CD44, CD133, dan miR-210.
2019 | BY Akmal Taher - Rianto Setiabudy - Diani Kartini - Sonar Soni Panigoro- The Effect of Melatonin in Combination with Neoadjuvant Chemotherapy to the Clinical Response of Squamous Cell Carcinoma of Locally Advanced Oral Cancer: a study on HIF1α, CD44, CD133, dan miR-210.
- Nomor Panggil D19013fk
Tesis
Hubungan Nilai Apparent Diffusion Coefficient (ADC) pada Diffusion Weighted - MRI (DW-MRI) Pra Pengobatan dengan Respon Kemoterapi Pada Karsinoma Sel Skuamosa Rongga Mulut Stadium Lokal Lanjut
2023 | BY Hendra Herizal - Ahmad Kurnia - Samuel J Haryono - Reyhan Eddy Yunus - H. Boy Subirosa Sabarguna- Association of pre-treatment Apparent Diffusion Coefficient (ADC) on Diffusion Weighted-MRI (DW-MRI) with chemotherapy response of advanced staged oral cancer.
- Nomor Panggil T23338fk
Tesis
Hubungan rasio trombosit limfosit dan rasio neutrofil limfosit darah dengan respons klinis pada pasien kanker paru karsinoma bukan sel kecil stage lanjut yang mendapat kemoterapi
2022 | BY Eliasta Simpar Sitepu - Dianiati Kusumo Sutoyo - Andika Chandra Putra - Jamal Zaini- Relationship between serum platelets to lymphocytes ratio and serum neutrophils to lymphocytes ratio with clinical response in advanced stage non-small cell lung cancer patients receiving chemotherapy.
- Nomor Panggil T22442fk
Tesis
Perbandingan Efikasi Dan Toksisitas Hematologi Kemoterapi Lini I Kanker Paru Karsinoma Bukan Sel Kecil (KPKBSK) Jenis Karsinoma Sel Skuamosa (KSS) Dengan Adenokarsinoma EGFR wild typeDi RSUP Persahabatan
2018 | BY Enita Mayasari - Elisna Syahruddin - Andika Chandra Putra- The Efficacy and Hematological Toxicity of First-line Chemotherapy of Non-small Cell Lung Cancer (NSCLC) Patients Treated at Persahabatan Hospital Jakarta, Indonesia .
- Nomor Panggil T18483fk
Tesis
Perubahan indeks massa tubuh, persentase otot rangka dan kadar albumin pada pasien kanker paru karsinoma bukan sel kecil ( KPKBSK ) sebelum dan setelah kemoterapi
2014 | BY Yenni Sari Siregar - Elisna Syahruddin - Wahju Aniwidyaningsih- Body mass index ( BMI), percentage of scletal muscle and albumin in non small cell lung cancer ( NSCLC) patiens before and after chemotherapy.
- Nomor Panggil T14583fk
Tesis
Angka tahan hidup pasien kangker paru kelompok bukan sel kecil non skuamosa yang mendapat terapi target Epidermal Growth Factor Receptor-Tyrosin Kinase Inhibitor dan yang mendapat Kemoterapi lini pertama di Rumah sakit Persahabatan
2014 | BY Sita Laksmi Andarini - Kasum Supriadi - Achmad Hudoyo- The survival rate of nonsquamous by non small cell lung carcinoma patiens who are given by target therapy epidermal growth facttor receptor-tyrosin kinase inhibitors and those given by first-line kemotheraphy treatment at Persahabatan hospital.
- Nomor Panggil T14579fk
Tesis
Masa tahan Hidup Pasien Kanker Paru Jenis Karsinoma Jenis Sel Kecil yang Mendapat Monoterapi Dosetaksel sebagai Kemoterapi Lini Kedua dan Faktor Faktor yang Mempengaruhi
2014 | BY Fadlun Bukayer - Anwar Jusuf - Elisna Syahruddin- SURVIVAL RATE OF DOCETAXEL AS SECONDLINE CHEMOTHERAPY FOR NSCLC PATIENTS IN PERSAHABATAN HOSPITAL JAKARTA.
- Nomor Panggil T14334fk